Google
Trusted Resources: News & Events
Latest announcements and gatherings
Meeting 5: Addressing Sickle Cell Disease: A Strategic Plan and Blueprint for Action
The Committee on Addressing Sickle Cell Disease: A Strategic Blueprint and Plan for Action will hold an open session for the public on Wednesday, September 11, 2019. This open session will include a panel of industry speakers who are currently developing therapeutic and curative products for sickle cell disease. The purpose of this session is to have manufacturers share their perspectives with the committee about the range of products in development, the regulatory process, and considerations for ensuring widespread access to pipeline products. More information about this session, including agenda and speakers will be forthcoming.
+myBinderRelated Content
-
Promising results at 1 year follow-up following familial haploidentical (FHI) T-cell depleted (TCD) with CD34 enrich...AlloSCT from HLA-matched MSD has been su...
-
Warrior University: Curative Therapies SeriesWarrior University is an online, curricu...
-
Chronic and acute anemia and extracranial internal carotid stenosis are risk factors for silent cerebral infarcts in...Early transcranial Doppler (TCD) screeni...
-
‘Every Time It’s A Battle’: In Excruciating Pain, Sickle Cell Patients Are Shunted AsideAmy Mason had toughed it out for hours o...
-
Only 21% of Kids with ADHD and SCD Are Treated for Attention DeficitA study of children with sickle cell dis...
-
Lisa Pullens, RN, BSN, CPHNLisa received her RN-BSN 33 years ago at...
-
TLC’s Tionne ‘T-Boz’ Watkins on Living With Sickle Cell DiseaseSinger Tionne "T-Boz" Watkins is opening...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.